Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | cyclin, putative | 0.0035 | 0.6419 | 0.0934 |
Schistosoma mansoni | cyclin B3 | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 2 | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclin b3 | 0.0035 | 0.6419 | 0.0934 |
Schistosoma mansoni | cyclins | 0.0035 | 0.6419 | 0.0934 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 1 | 1 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Loa Loa (eye worm) | AGC/PKA protein kinase | 0.004 | 1 | 1 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Entamoeba histolytica | cyclin, putative | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 3 | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | enhancer of mRNA decapping protein 4 | 0.004 | 0.9654 | 0.9125 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.004 | 1 | 1 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.0035 | 0.6419 | 0.0934 |
Leishmania major | protein kinase A catalytic subunit isoform 2 | 0.004 | 1 | 1 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 3 | 0.004 | 1 | 1 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 1 | 0.004 | 1 | 1 |
Toxoplasma gondii | protein kinase, cAMP-dependent, catalytic chain | 0.004 | 1 | 1 |
Giardia lamblia | Kinase, AGC PKA | 0.004 | 1 | 1 |
Entamoeba histolytica | cyclin family protein | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Schistosoma mansoni | cyclin B | 0.0035 | 0.6419 | 0.0934 |
Onchocerca volvulus | 0.0035 | 0.6419 | 0.5 | |
Leishmania major | protein kinase A catalytic subunit isoform 1 | 0.004 | 1 | 1 |
Leishmania major | protein kinase A catalytic subunit | 0.004 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.004 | 1 | 1 |
Echinococcus granulosus | enhancer of mRNA decapping protein 4 | 0.004 | 0.9654 | 0.9125 |
Plasmodium vivax | cAMP-dependent protein kinase catalytic subunit, putative | 0.004 | 1 | 0.5 |
Entamoeba histolytica | cyclin family protein | 0.0035 | 0.6419 | 0.0934 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0035 | 0.6419 | 0.0934 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Trypanosoma brucei | cAMP-dependent protein kinase catalytic subunit 1 | 0.004 | 1 | 1 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Toxoplasma gondii | AGC kinase | 0.004 | 1 | 1 |
Echinococcus granulosus | cyclin B3 1 | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cAMP dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Plasmodium falciparum | cAMP-dependent protein kinase catalytic subunit | 0.004 | 1 | 1 |
Trypanosoma brucei | protein kinase A catalytic subunit, putative | 0.004 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclin B | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Trichomonas vaginalis | AGC family protein kinase | 0.004 | 1 | 1 |
Echinococcus granulosus | cyclin b3 | 0.0035 | 0.6419 | 0.0934 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.0035 | 0.6419 | 0.0934 |
Echinococcus multilocularis | cyclin B3 1 | 0.0035 | 0.6419 | 0.0934 |
Trypanosoma brucei | cAMP-dependent protein kinase catalytic subunit 2 | 0.004 | 1 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.004 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.004 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0035 | 0.6419 | 0.0934 |
Echinococcus granulosus | cyclin B | 0.0035 | 0.6419 | 0.0934 |
Loa Loa (eye worm) | AGC/PKA protein kinase | 0.004 | 1 | 1 |
Toxoplasma gondii | AGC kinase | 0.004 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0 % | Inhibition of the binding of [3H]-LSD on rat 5-HT7R in HEK-293 cells at concentration of 10e-8 M | ChEMBL. | 16002287 |
Inhibition (binding) | = 0 % | Inhibition of the binding of [3H]-LSD on rat 5-HT7R in HEK-293 cells at concentration of 10e-8 M | ChEMBL. | 16002287 |
Inhibition (binding) | = 6 % | Inhibition of the binding of [3H]-LSD on rat 5-HT7R in HEK-293 cells at concentration of 10e-6 M | ChEMBL. | 16002287 |
Inhibition (binding) | = 6 % | Inhibition of the binding of [3H]-LSD on rat 5-HT7R in HEK-293 cells at concentration of 10e-6 M | ChEMBL. | 16002287 |
Ki (binding) | 0 nM | Binding affinity against rat 5-HT7R expressed in HEK-293 cells; ND = not determined | ChEMBL. | 16002287 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.